NNP
BSX icon

Nachman Norwood & Parrott’s Boston Scientific BSX Stock Holding History

Nachman Norwood & Parrott’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,702
Closed -$65K – 360
2020
Q3 		$65K Buy
+1,702
New +$65.6K 0.01% 391

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Nachman Norwood & Parrott's BSX Position: Q4 2020 in Review

Nachman Norwood & Parrott sold out of Boston Scientific (BSX) in Q4 2020, closing a stake of 1,702 shares — an estimated $65K sold.

Nachman Norwood & Parrott first reported a position in BSX in Q3 2020 and held it in 1 quarter. The position peaked at $65K in Q3 2020. 863 funds tracked by Wall St. Rank hold BSX as of Q4 2020.

  • Nachman Norwood & Parrott reported no remaining Boston Scientific position as of Q4 2020 after selling out during the quarter.
  • Nachman Norwood & Parrott sold 1,702 Boston Scientific shares in Q4 2020, an estimated $65K.
  • Nachman Norwood & Parrott first reported a position in Boston Scientific in Q3 2020 and held it in 1 quarter.
  • Nachman Norwood & Parrott's Boston Scientific position peaked at $65K in Q3 2020.
  • 863 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q4 2020, filed 19 Jan 2021.